New Hiv Therapy Boosts Immunity And Reduces Viral Replication
The study, co-authored by Yale assistant professor of medicine Brinda Emu, M.D., was published in the New England Journal of Medicine. For some individuals with HIV, existing drug therapies fail to suppress the virus, leading to drug resistance and worsening disease. While several HIV drugs target the virus effectively, there has not been a new class of HIV drugs approved to combat the disease in a decade. In March 2018, the FDA approved ibalizumab, a drug that targets the primary receptor for HIV entry into immune cells known as CD4 T cells....